Letters, Testimony & Comments

June 24, 2003
Dear Chairman Thomas, Tauzin and Grassley: As conference begins on reconciling the differences between the House and Senate versions of Medicare prescription drug legislation, we urge you to maintain the strong safety requirements pertaining to...
June 17, 2003
Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, Maryland 20852 Re: Docket No. 03D-0229, Federal Register: June 17, 2003 (Volume 68, Number 116, Page 35903) Dear Sir/Madam: The...
June 12, 2003
Statement of Michael J. Werner, Esq. Vice President, Bioethics Biotechnology Industry Organization Before the President's Council on Bioethics June 12, 2003 Good afternoon Mr. Chairman and members of this distinguished council. My name...
May 29, 2003
Dear Sir/Madam: The following comments supplement those presented by the Biotechnology Industry Organization (BIO) at FDA's public meeting to discuss the Risk Management Concept Papers on April 9-11, 2003. BIO represents more than 1,000...
May 29, 2003
Dear Sir/Madam: The following comments supplement those presented by the Biotechnology Industry Organization (BIO) at FDA's public meeting to discuss the Risk Management Concept Papers on April 9-11, 2003. BIO represents more than 1,000...
May 29, 2003
Dear Sir/Madam: The following comments supplement those presented by the Biotechnology Industry Organization (BIO) at FDA's public meeting to discuss the Risk Management Concept Papers on April 9-11, 2003. BIO represents more than 1,000...
May 19, 2003
Supporting legislation that prohibits genetic discrimination.
May 13, 2003
Administrator, U.S. Small Business Administration
April 15, 2003
Leon R. Kass, M.D., Chairman The President's Council on Bioethics 1801 Pennsylvania Avenue, NW Suite 800 Washington, DC 20005   Dear Dr. Kass: Thank you for your letter of March 14, 2003./1 In response, the Biotechnology...
March 27, 2003
J. Leighton Read, M.D. General Partner, Alloy Ventures Palo Alto, CA Testifying On Behalf Of The Biotechnology Industry Organization Before The House Energy And Commerce Subcommittee On Health And The House Select Committee On Homeland...
February 14, 2003
The Honorable Mark B. McClellan Commissioner United States Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, Maryland 20852 Re: Personal Importation of Biological Products Dear Dr. McClellan: The Biotechnology Industry...
February 14, 2003
Identifying countries of concern as per the Trade Act of 1974
January 29, 2003
Letter to The Honorable Robert Zoellick, US Trade Representative
January 17, 2003
When I read the agenda for today and saw the emphasis on corporate strategy, it reminded me of a quote by financier Victor Palmieri, who said: "Strategies are okayed in boardrooms that even a child would say are bound to fail. "The...